title: A study of danazol's safety.
abstract: In a review of medical records of 530 recipients of danazol at Group Health Cooperative of Puget Sound, we identified 154 (29%) people who reported at least one adverse event that occurred within 45 days after receiving the drug. In no patient did the event require hospitalization, and there were no known long-term sequelae.
authors.affiliation: Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA 02173, USA.
authors.forename: S S
authors.initials: SS
authors.lastname: Jick
authors.forename: M W
authors.initials: MW
authors.lastname: Myers
mesh_terms: D000328:Adult; D003613:Danazol / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D004715:Endometriosis / Q000188:drug therapy; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D012189:Retrospective Studies
chemical_list: D004965:Estrogen Antagonists; D003613:Danazol